MAVS and small cell lung carcinoma: We report a proof-of-concept clinical study evaluating a surface plasmon resonance-plastic optical fiber (SPR‐POF) biosensor functionalized with anti-MAVS antibodies to detect the protein in serum from SCLC patients undergoing chemo-immunotherapy, with or without radiotherapy.